USITC Commissioner Series: What Divides the International Trade Commission?
May 1, 2024, 8:12 AM
At the International Trade Commission, a panel of up to six Commissioners is the gatekeeper of Section 337. Before the termination of any investigation, an administrative law judge's initial determination is always subject to Commission review. However, the Commissioners do not always agree and have recently shown increasing disparity on issues focused on the nuance of Section 337, like the domestic industry requirement and forms of remedy. To help navigate these disagreements, below is a comprehensive and searchable resource for all Commissioner dissents and concurrences over the last ten years. (Last updated through December 2023)
Search by Investigation Number: e.g., 1344, 794, 1190
Search by Issue: e.g., Remedy, CDO, Domestic Industry, Infringement
Search by Commissioner: e.g., Stayin, Johanson, Kearns
Our coverage in the USITC Commissioner Series details some of the key conclusions that can be drawn from this data. Read part one here, part two here, part three here and part five here.
To help visualize, below is an interactive identification of all dissents and concurrences. The data can be grouped or shaded by issue or commissioner. They can also be resized by the length of the opinion.

To subscribe to our publications, click here.
News & Insights
News & Insights
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
GCR Live Global: Navigating the Future of Antitrust 2026
Speaking Engagement
Antitrust
Stakeholders 25th Annual CYOC Career Development Conference
Sponsorship
Antitrust
American Investment Council’s General Counsel Day
Speaking Engagement
Antitrust
Informa 34th Annual Advanced EU Brussels Conference
Speaking Engagement
Antitrust
Kisaco Research Pharma and Biotech Patent Litigation Summit 2025
Speaking Engagement
Intellectual Property
GCR Live: Women in Antitrust 2025
Speaking Engagement
Antitrust
Global Legal Group Global Class Actions Symposium 2025
Speaking Engagement
Litigation & Trials
Biosimilar Approval Pathway Changes Sponsors Need to Monitor
Media Mentions
Intellectual Property